logo

Stealth Biotherapeutics Corp (MITO)



Trade MITO now with
  Date
  Headline
4/13/2020 8:26:47 AM Stealth Biotherapeutics Announces $20 Mln Financing
4/1/2020 7:32:07 AM Stealth BioTherapeutics FY Loss Per Share $0.19 Vs Loss $1.41 Last Year
3/3/2020 7:32:42 AM Stealth BioTherapeutics: FDA Grants Rare Pediatric Disease Designation For Elamipretide For Barth Syndrome
1/21/2020 7:34:14 AM Stealth BioTherapeutics Initiates First-in-Human Study Of SBT-272
12/20/2019 8:02:00 AM Stealth BioTherapeutics Updates On Phase 3 Trial Of Elamipretide In Primary Mitochondrial Myopathy
11/14/2019 7:18:37 AM Stealth BioTherapeutics Q3 Net Loss $16.5 Mln Or $0.04/Shr Vs Loss $22.7 Mln Or $0.33/Shr Last Year
10/17/2019 7:32:40 AM Stealth BioTherapeutics Presents Data For Elamipretide On Cardiac Function In Barth Syndrome
10/10/2019 7:35:28 AM Alexion,Stealth Announce Deal For Option To Co-Develop And Commercialize Elamipretide For Mitochondrial Diseases
9/3/2019 4:42:51 PM Stealth BioTherapeutics Appoints Robert Weiskopf As CFO
8/14/2019 4:23:11 PM Stealth BioTherapeutics Q2 Loss/share $0.04 Vs. Loss $0.40 Year Ago
5/15/2019 4:20:58 PM Stealth BioTherapeutics Q1 Loss/share $0.20 Vs. Loss $0.30 Year Ago